Rick St John
About
Rick St John is from South San Francisco, California, United States. Rick works in the following industries: "Biotechnology Research". Rick is currently Senior Director, Protein Development and Manufacturing at Vaxcyte, located in Foster City, California, United States. In Rick's previous role as a Director, Head of Digital Sciences, Pharma Technical Development, US at Genentech, Rick worked in South San Francisco, California until Apr 2021. Prior to joining Genentech, Rick was a Director, Process Development Engineering at Genentech and held the position of Director, Process Development Engineering. Prior to that, Rick was a Sr. Group Leader, Purification Development at Genentech from May 2009 to Jun 2015. Rick started working as Group Leader, Purification Development at Genentech in Jun 2007. From Oct 2006 to May 2007, Rick was Senior Scientist at Nuvelo. Prior to that, Rick was a Principal Scientist at Novartis AG from Apr 2006 to Oct 2006. Rick started working as Principal Scientist at Chiron Corp in Sep 2001.
You can find Rick St John's email on finalScout.com. FinalScout is a popular professional database with more than 500 million business professionals and over 200 million company profiles.
Rick St John's current jobs
Lead of Vaxcyte's protein development and manufacturing group. We are focused on delivering Vaxcyte's pipeline by delivering protein components of our cutting edge vaccines as well as managing the complex supply chains needed for clinical and commercial supply.
Rick St John's past jobs
Leading digital strategy and execution for US biologics development and driving digital transformation for biologics development and all of pharma technical operations through collaborative teams. I work in a highly collaborative, cross-functional environment to progress digital transformation through strategies, technical advances, and people engagement.
Leader of a biologics development engineering function focused on automation, data management, and process engineering innovation. We worked closely with our development scientists, pilot plants, and manufacturing to scale up solutions, increase efficiency through automation and data utilization, and advance manufacturing through single use, PAT, and process innovations. From this position, I was instrumental in initiating and leading our global digital transformation initiative for global process development at Roche.
Leader of a sub-group in Purification Development of up to 20 scientists and engineers developing biologics downstream processes for the full range of portfolio molecules at Genentech. In this role, I assumed leadership of innovation and Quality by Design strategies in our department and across global Roche.
Leader of a small group, a late stage project team, and laboratory scientist